Contact
Roles
Professor of Clinical Medicine
Chief, Division of Medical Oncology
Associate Director for the Cancer Center and Medical Director for International Affairs, Sylvester Comprehensive Cancer Center
-
Biography
Dr. Gilberto Lopes is a medical oncologist and researcher who focuses on new anticancer drug development and global oncology. He has published more than 270 scientific papers and has led hundreds of clinical trials. Dr. Lopes was the main investigator of Keynote 42, a clinical trial that demonstrated the efficacy of the immunotherapy drug pembrolizumab in people living with lung cancer. This groundbreaking study led to one of the FDA approvals of pembrolizumab. Additionally, Dr. Lopes has contributed significantly to the development of several chemotherapies and targeted medications that address specific molecular changes in tumors. He also does research in cancer control, policy and health economics and is active in improving access to cancer medications in underserved settings. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
No result found
-
Teaching Interests
Oncology, health policy, health economics, drug development. -
Research Interests
Lung cancer, drug development, access to cancer medications, health economics, health policy. -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
-
Professional Activities
No result found